SLRX (Salarius Pharmaceuticals Inc) Gunggung Aset Perusahaan

Simbol resmi perusahaan Salarius Pharmaceuticals Inc (SLRX)

Salarius Pharmaceuticals (SLRX) is currently in the clinical trial stage without a stable cash flow, and its liquidity stands at 4.97. The company is mitigating risks by developing epigenetic therapies to combat rare tumors. This chart of the aggregate asset market price confirms the potential of the business, whose patents for enzyme inhibitors will ensure a prolonged period of exclusivity and sustained demand from medical professionals.

Aset Agregat Perusahaan Salarius Pharmaceuticals Inc (SLRX): kanggo periode 04.07.2022 - 08.01.2026

Rincian metrik keuangan lan pasar Salarius (SLRX)

- kuotasi lan prakiraan analis:
Kurs saham salariuspharma.com|SLRX - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar Salarius Pharma|SLRX - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Salarius Pharmaceuticals|SLRX - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku salariuspharma.com|SLRX - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Salarius Pharmaceuticals|SLRX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Salarius Pharma|SLRX - Utang perusahaan|Rasio utang marang aset resik Salarius Pharma|SLRX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Salarius Pharmaceuticals|Indikator likuiditas cepet salariuspharma.com
- rincian bathi lan kelipatan pasar:
SLRX - Penghasilan resik
Analisis dhasar perusahaan:salariuspharma.com (SLRX)
Barang utama Salarius Pharmaceuticals, Inc.

Since this metric is calculated inversely via ROA, it reacts sharply to operating profit volatility, measuring the total volume of resources and liabilities to assess financial stability. In the case of Salarius Pharmaceuticals (SLRX), this reflects the ability to maintain complex chemical formula supply chains and the diversification of research bases, which is confirmed through the monitoring of total assets (via ROA).

Pesaing wigati

Total Aset Bisnis ONC|HALO (Halozyme) - Total Aset Perusahaan|Gunggung Aset Perusahaan Revolution Medicines Inc (RVMD)|Total Aset Perusahaan AAPG|Total Aset Perusahaan CG Oncology Therapeutics (CGON)|Aset Agregat Perusahaan UroGen Pharma Ltd. URGN|BCAX: Total Aset Bisnis|Personalis - Total Aset Perusahaan|Erasca Inc (ERAS) - Gunggung Aset Perusahaan|DCTH: Total Aset Perusahaan|Aset Perusahaan Y-mAbs Corp (YMAB)|Aset Agregat Perusahaan Aura Biosciences, Inc.|CADL: Nilai Agregat Aset|Gunggung Aset Perusahaan ARAY (Accuray)|SLS (sellaslifesciences.com) - Nilai Agregat Aset|Total Aset Perusahaan ACTU (Actuate Therapeutics, Inc)|CTOR - Gunggung Aset Perusahaan|HURA: Gunggung Aset Perusahaan|TARA - Total Aset Perusahaan|Fate Therapeutics (FATE) - Aset Agregat Perusahaan|Aadi Bioscience - Nilai Agregat Aset|TCRX (TScan Therapeutics Inc) - Total Aset Perusahaan|Aset Perusahaan Champions Oncology Corp CSBR|Aset Agregat Perusahaan XBiotech Inc. (XBIT)|Gunggung Aset Perusahaan cel-sci.com|Total Aset Perusahaan OSTX (OS Therapies)|Total Aset Perusahaan radiopharmtheranostics.com RADX|ARTV - Aset Agregat Perusahaan|ANL: Aset Agregat Perusahaan|VERU: Total Aset Perusahaan|tempesttx.com (TPST) - Total Aset Perusahaan|Aset Agregat Perusahaan Xilio Therapeutics Inc|RENB: Nilai Agregat Aset|Total Aset Perusahaan MURA|Gunggung Aset Perusahaan kairospharma.com|OnKure Therapeutics - Gunggung Aset Perusahaan|Total Aset Perusahaan CytoMed Therapeutics Ltd GDTC|CRIS - Aset Agregat Perusahaan|Gunggung Aset Perusahaan Apollomics, Inc. APLM|THAR (Tharimmune Corp) - Gunggung Aset Perusahaan|Advanced Biomed - Nilai Agregat Aset|Aset Agregat Perusahaan Genprex, Inc.|Calidi Bio - Nilai Total Aset Perusahaan|Total Aset Perusahaan SBFM|XBIO (xeneticbio.com) - Nilai Agregat Aset|Total Aset Perusahaan PPBT (Purple Biotech Corp)|Total Aset Perusahaan American Oncology Network Inc AONC|BGNE - Aset Agregat Perusahaan|Nilai Agregat Aset CKPT (checkpointtx.com)|Elevation Oncology (ELEV) - Aset Agregat Perusahaan|Gunggung Aset Perusahaan iCAD|IKNA (Ikena Oncology Inc.) - Total Aset Perusahaan|Total Aset Perusahaan Notable Labs Corp|Total Aset Perusahaan VIRX|Gunggung Aset Perusahaan morphosys.com MOR|Total Aset Perusahaan NAYA (NAYA Biosciences Inc.)|Ascentage Pharma Group International (AAPGV) - Aset Perusahaan